Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
September 3, 2024
BUY150.323k0.0589%ARKK
August 30, 2024
BUY85.208k0.0336%ARKK
August 14, 2024
BUY147.574k0.0601%ARKK
August 13, 2024
BUY72.988k0.0313%ARKK
August 12, 2024
BUY20.178k0.0082%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.06%$2.01b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
16🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
200$62.04
🎫ARK Ownership Percent
0.15%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA